1190-55-2

Basic information

• Product Name: 3,7,11-Trimethyldodecanoic acid
• Synonyms: 3,7,11-Trimethyldodecanoic acid;Farnesanoic acid
• CAS NO: 1190-55-2
• Molecular Formula: C₁₅H₃₀O₂
• Molecular Weight: 242.4
• Mol File: 1190-55-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 349.9°C at 760 mmHg
• Flash Point: 156.6°C
• Appearance: /
• Density: 0.891g/cm³
• Vapor Pressure: 7.86E-06mmHg at 25°C
• Refractive Index: 1.449
• CAS DataBase Reference: 3,7,11-Trimethyldodecanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3,7,11-Trimethyldodecanoic acid(1190-55-2)
• EPA Substance Registry System: 3,7,11-Trimethyldodecanoic acid(1190-55-2)

Safety Data

• Hazardous Substances Data: 1190-55-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C15H30O2/c1-12(2)7-5-8-13(3)9-6-10-14(4)11-15(16)17/h12-14H,5-11H2,1-4H3,(H,16,17)

Upstream product

• 40596-48-3 3,7,11-trimethyl-dodeca-2,4,10-trienoic acid 
• 60148-92-7 3,7,11-trimethyl-dodec-2-enoic acid 
• 6750-34-1 3,7,11-trimethyldodecyl alcohol 
• 13835-41-1 6,10-dimethyl-undeca-3,9-dien-2-one 
• 3918-42-1 3-hydroxy-3,7,11-trimethyl-dodecanoic acid ethyl ester 
• 29548-30-9 farnesyl acetate 
• 4602-84-0 farnesol 
• 13955-70-9 (R)-(-)-4,8-dimethylnonanoic dcid 
• 13853-23-1 monobenzyl 3-methylglutarate 
• 59965-20-7 (R)-1-bromo-3,7-dimethyloctane 
• 1117-61-9 (3R)-citronellol 
• 85253-85-6 D-4,8-dimethyl-nonanenitrile 
• 1117-60-8 (R)-3,7-dimethyloctan-1-ol 
• 13853-24-2 (R)-3,7-dimethyl-octanoic acid methyl ester 

Downstream Products

• 502-69-2 (6Ξ,10R)-6,10,14-trimethyl-pentadecan-2-one 

Relevant articles and documents

AMPHIPHILE PRODRUGS

Amphiphilic prodrugs of general formula A-X are disclosed, wherein A is a biologically active agent or may be metabolised to a biologically active agent; and X is selected from the group consisting of R, or up to three R moieties attached to a linker, Y1, Y2 or Y3, wherein R is selected from a group consisting of alkyl, alkenyl, alkynyl, branched alkyl, branched alkenyl, branched alkynyl, substituted alkyl, substituted alkenyl and substituted alkynyl groups and their analogues; Y1 is a linker group which covalently attached to an R group at one site and is attached to A at a further independent site; Y2 is a linker group which is covalently attached to two R groups at two independent sites and is attached to A at a further independent site; and Y3 is a linker group which is covalently attached to three R groups at three independent sites and is attached to A at a further independent site. Self-assembly of the amphiphilic prodrugs into reverse lyotropic phases, particularly hexagonal, cubic and sponge, is disclosed. In preferred embodiments A is dopamine or a 5-fluorouracil prodrug.